Working with Tesaro
The TESARO team has a track record of success in identifying, acquiring, developing and commercializing oncology therapeutics and supportive care products that make a meaningful difference in the lives of patients.
Our interests are aligned with those of our partners, and we have a proven track record of successful product development and global commercialization. We are selective in the number and type of alliances that we participate in, thus enabling us to provide a high level of attention to each partner and product.
TESARO has forged several successful licensing agreements with OPKO Health, Amgen, Merck, and AnaptysBio. For more details, click here.
We invite the submission of business development proposals via email to BD@tesarobio.com.
Please note that any business development proposals that are submitted to TESARO via email or via our web site will be considered non-confidential. No information exchange may be deemed confidential without a signed confidentiality or disclosure agreement from TESARO.
Other Ways to Partner With Us
Relationships are vital to the success of our business. We are committed to being a trusted partner to the cancer community, so we pursue a wide range of projects with a clear strategic fit with our portfolio:
We look for promising partnerships focused toward the development of clinical drug candidates for cancer patients. Ideal partnerships involve research centric groups or organizations seeking development partners to advance new therapeutic concepts toward clinical candidates. The ultimate aim is to progress appropriate clinical candidates into clinical trials.
Our translational research program focuses on understanding mechanism-of-action of our drugs, identifying patients most likely to benefit from treatment, and informing new combination treatment strategies for patients with advanced cancers.
This program is open to all researchers who are interested in conducting their own clinical research. External investigators can collaborate with R&D experts at TESARO to develop clinical trials, and may receive compound and/or funding to support independent research activities.